Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Directorate change - NED changes

13th Nov 2026 07:00

RNS Number : 0146D
Rentokil Initial PLC
13 November 2026
 

Directorate Change: Non-executive Director changes

 

Rentokil Initial plc (FTSE: RTO, NYSE: RTO, the ‘Company’) today announces the appointment of Duncan Palmer as a Non-executive Director, with immediate effect.

Duncan is a former Chief Financial Officer and current non-executive director, with significant international experience across major companies. He most recently served as Chief Financial Officer of Cushman & Wakefield (NYSE: CWK), the global real estate commercial services company, where he was a leader in their consolidation and integration strategy and led their US public offering. He was previously CFO at RELX plc (FTSE: RELX) and Owens Corning (NYSE: OC), and held a series of finance leadership roles at Shell. He has deep expertise in finance and governance and a proven track record in implementing back-office rationalisation, cost-reduction, and M&A integration. He currently holds non-executive directorships at Oshkosh Corporation (NYSE: OSK), where he is Chair of the Audit Committee, and also at Aleanna (ANNA) and Verde Clean Fuels (VGAS).

Duncan is a UK Chartered Management Accountant and holds an MBA from the Stanford Graduate School of Business and an MA from St John’s College, Cambridge.

The Company also announces that David Frear will be stepping down from the Board, effective 30 November 2026.

Thérèse Esperdy, Chair, said:

‘I am delighted to welcome Duncan to the Board as a Non-executive Director. His financial skills and transformation experience will greatly benefit the Board and support our management team as we execute our strategic plans, particularly in North America. I would also like to thank David for his commitment and valuable contributions to the Board, Remuneration and Nomination Committees over the last four years.’

Duncan will also become a member of the Audit Committee and the Nomination Committee.

There are no further details to be disclosed relating to Duncan Palmer under Section 6.4.8 of the UK Listing Rules.

​

Enquiries:

For further information, please contact:

Investors / Analysts:

Heather Wood, Rentokil Initial plc, +44 7808 098793

Jamie Lewis, Rentokil Initial plc, +44 7341 071944

Media:

Malcolm Padley, Rentokil Initial plc, +44 7788 978 199

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAAKBBKFBDDODD

Related Shares:

Rentokil Initial
FTSE 100 Latest
Value10,902.56
Change39.47